PSMA binding agents and uses thereof
US11746157B2 · kind B2 · utility
1Cited by
41References
81Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2019 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Mar 29, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specifically binding PSMA or PSMA and CD3, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.